- Company Overview for GENZYME THERAPEUTICS LIMITED (04316333)
- Filing history for GENZYME THERAPEUTICS LIMITED (04316333)
- People for GENZYME THERAPEUTICS LIMITED (04316333)
- More for GENZYME THERAPEUTICS LIMITED (04316333)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
06 Jul 2024 | AA | Full accounts made up to 31 December 2023 | |
03 Mar 2024 | AP01 | Appointment of Rippon Ubhi as a director on 1 March 2024 | |
01 Mar 2024 | TM01 | Termination of appointment of Jessamy Rachel Baird as a director on 1 March 2024 | |
02 Feb 2024 | CS01 | Confirmation statement made on 31 December 2023 with no updates | |
18 Jul 2023 | AA | Full accounts made up to 31 December 2022 | |
06 Jan 2023 | CS01 | Confirmation statement made on 31 December 2022 with no updates | |
14 Oct 2022 | AP01 | Appointment of Ms Jessamy Rachel Baird as a director on 1 October 2022 | |
14 Oct 2022 | TM01 | Termination of appointment of Nicole Suzanne Farmer as a director on 1 October 2022 | |
15 Jul 2022 | AA | Full accounts made up to 31 December 2021 | |
07 Feb 2022 | CS01 | Confirmation statement made on 31 December 2021 with no updates | |
28 Jul 2021 | AA | Full accounts made up to 31 December 2020 | |
08 Apr 2021 | AP01 | Appointment of Mr Usman Khan as a director on 31 March 2021 | |
07 Apr 2021 | AA | Full accounts made up to 31 December 2019 | |
03 Apr 2021 | TM01 | Termination of appointment of Francois-Xavier Duhalde as a director on 31 March 2021 | |
11 Mar 2021 | CS01 | Confirmation statement made on 31 December 2020 with updates | |
02 Jun 2020 | AP01 | Appointment of Ms Nicole Suzanne Farmer as a director on 16 May 2020 | |
29 May 2020 | TM01 | Termination of appointment of Peter Sjoerd Kuiper as a director on 16 May 2020 | |
13 Jan 2020 | CS01 | Confirmation statement made on 31 December 2019 with updates | |
09 Oct 2019 | AA | Full accounts made up to 31 December 2018 | |
03 Oct 2019 | PSC05 | Change of details for Aventis Pharma Limited as a person with significant control on 15 July 2019 | |
15 Jul 2019 | AD01 | Registered office address changed from 4620 Kingsgate Cascade Way Oxford Business Park South Oxford Oxfordshire OX4 2SU to 410 Thames Valley Park Drive Reading Berkshire RG6 1PT on 15 July 2019 | |
14 May 2019 | PSC02 | Notification of Aventis Pharma Limited as a person with significant control on 30 April 2019 | |
14 May 2019 | PSC07 | Cessation of Sanofi-Aventis Uk Holdings Limited as a person with significant control on 30 April 2019 | |
08 Feb 2019 | AA | Full accounts made up to 31 December 2017 | |
12 Jan 2019 | DISS40 | Compulsory strike-off action has been discontinued |